s6y Can-Fite BioPharma Ltd. EFFECT

Can-Fite BioPharma Ltd. EFFECT, filed Apr 24, 2023: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 24, 2023
Accession Number: 0001213900-23-031684
Submission Type: POS AM
CIK: 0001536196
Company Name: Can-Fite BioPharma Ltd.
File Number: 333-259085